secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001493152-23-008077
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q2 net loss widens to $1.06M; CEO Tom Y. Lee resigns, Robert Bartlett appointed
--------------------------------------------------------------------------------

- Q2 net product sales $396K, down ~4.6% YoY; net loss $1.06M vs $702K prior year.
- Six-month net loss $2.05M vs $1.50M; loss per share ($0.02) unchanged.
- CEO Tom Y. Lee resigned March 15; Robert Bartlett named President and CEO.
- Tom Myers transitions from COO to EVP Technology & Development for sales and R&D focus.
- New CEO says prior sales approach lackluster; plans to refocus on new and existing channels.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223008077/0001493152-23-008077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315223008077/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer